As more states legalize the sale of marijuana and its components, there is concern for how they might impact fetal and neonatal health. A recent article released by the U.S. Food and Drug Administration (FDA) states it strongly advises not to use cannabidiol (CBD), tetrahydrocannabinol (THC), and marijuana in any form during pregnancy or while breastfeeding.
There is a paucity of research, however, data indicates there are risks associated with the use of these substances during pregnancy and breastfeeding. Given current knowledge of CBD and risks to the human body such as, liver toxicity due to contaminants, the article indicates there is concern that it may harm a fetus or breastfed baby. Preliminary data suggests tetrahydrocannabinol (THC), which is the chemical responsible for most of marijuana’s psychological effects, can be transferred to unborn and breastfed infants through the excretion of breast milk and the placenta. This psychoactive component is stored in body fat, which can remain in an infant for long periods due to infants’ high percentage of body fat; several studies have found the duration of THC in breast milk is ~6 days. Click HERE to read the full article.
Back to News